Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

ERS Congress 2024

Keep up to date on the latest news from the annual European Respiratory Society conference.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in:

Open Access 03-05-2024 | Childhood Asthma | Review

Objective monitoring tools for improved management of childhood asthma

Authors: Phillip L.W. Au-Doung, Jason C.H. Chan, Oliver Y.H. Kui, Marco K.Y. Ho, Yin Ting Cheung, Jenny K.W. Lam, Hak-Kim Chan, John Brannan, Kate C.C. Chan, Albert M. Li, Sharon S.Y. Leung

Published in: Respiratory Research | Issue 1/2024

Login to get access

Abstract

Asthma is a common chronic disease amongst children. Epidemiological studies showed that the mortality rate of asthma in children is still high worldwide. Asthma control is therefore essential to minimize asthma exacerbations, which can be fatal if the condition is poorly controlled. Frequent monitoring could help to detect asthma progression and ensure treatment effectiveness. Although subjective asthma monitoring tools are available, the results vary as they rely on patients’ self-perception. Emerging evidence suggests several objective tools could have the potential for monitoring purposes. However, there is no consensus to standardise the use of objective monitoring tools. In this review, we start with the prevalence and severity of childhood asthma worldwide. Then, we detail the latest available objective monitoring tools, focusing on their effectiveness in paediatric asthma management. Publications of spirometry, fractional exhaled nitric oxide (FeNO), hyperresponsiveness tests and electronic monitoring devices (EMDs) between 2016 and 2023 were included. The potential advantages and limitations of each tool were also discussed. Overall, this review provides a summary for researchers dedicated to further improving objective paediatric asthma monitoring and provides insights for clinicians to incorporate different objective monitoring tools in clinical practices.
Literature
1.
Asher MI, Rutter CE, Bissell K, Chiang C-Y, El Sony A, Ellwood E, et al. Worldwide trends in the burden of asthma symptoms in school-aged children: global Asthma Network Phase I cross-sectional study. Lancet. 2021;398(10311):1569–80.PubMedPubMedCentralCrossRef
2.
3.
Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Asthma Nat Reviews Disease Primers. 2015;1(1):15025.PubMedCrossRef
4.
Everhart RS, Fiese BH. Asthma severity and child quality of life in pediatric asthma: a systematic review. Patient Educ Couns. 2009;75(2):162–8.PubMedCrossRef
5.
Beasley R, Ellwood P, Asher I. International patterns of the prevalence of pediatric asthma the ISAAC program. Pediatr Clin North Am. 2003;50(3):539–53.PubMedCrossRef
6.
7.
Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–40.PubMedCrossRef
8.
Zhang D, Zheng J. The Burden of Childhood Asthma by Age Group, 1990–2019: a systematic analysis of global burden of disease 2019 data. Front Pediatr. 2022;10:823399.PubMedPubMedCentralCrossRef
9.
Mariëlle WP, Eugenio B, Paul LPB, Kai-Håkon C, Ernst E, Thomas F, et al. Monitoring asthma in children. Eur Respir J. 2015;45(4):906.CrossRef
10.
Wong GWK, Kwon N, Hong JG, Hsu J-Y, Gunasekera KD. Pediatric Asthma control in Asia: phase 2 of the Asthma insights and reality in Asia-Pacific (AIRIAP 2) survey. Allergy. 2013;68(4):524–30.PubMedCrossRef
11.
Wang H-C, Djajalaksana S, Sharma L, Theerakittikul T, Lim HF, Yoo KH, et al. Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: findings from the SABA use IN Asthma (SABINA) study in Asia. World Allergy Organ J. 2023;16(10):100823.PubMedPubMedCentralCrossRef
12.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4).
13.
Kansen HM, Le TM, Uiterwaal C, van Ewijk BE, Balemans W, Gorissen D, et al. Prevalence and predictors of uncontrolled asthma in children referred for Asthma and Other Atopic diseases. J Asthma Allergy. 2020;13:67–75.PubMedPubMedCentralCrossRef
14.
Achakulwisut P, Brauer M, Hystad P, Anenberg SC. Global, national, and urban burdens of paediatric asthma incidence attributable to ambient NO < sub > 2 pollution: estimates from global datasets. Lancet Planet Health. 2019;3(4):e166–78.PubMedCrossRef
15.
16.
Butz AM, Ogborn J, Mudd S, Ballreich J, Tsoukleris M, Kub J, et al. Factors associated with high short-acting β2-agonist use in urban children with asthma. Ann Allergy Asthma Immunol. 2015;114(5):385–92.PubMedPubMedCentralCrossRef
17.
Rietveld S. Symptom perception in asthma: a multidisciplinary review. J Asthma. 1998;35(2):137–46.PubMedCrossRef
18.
Alexander M, Kai-Hakon C, Peter DS, Eugenio B, Giorgio P, Ian P, et al. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. Eur Respiratory Rev. 2015;24(136):204.CrossRef
19.
Buzoianu E, Moiceanu M, Plesca DA. Asthma Control Assessment in Children: correlation between Asthma Control Test and Peak Expiratory Flow. Maedica (Bucur). 2014;9(4):338–43.PubMed
20.
Fielding S, Pijnenburg M, de Jongste JC, Pike KC, Roberts G, Petsky H, et al. Change in FEV(1) and feno measurements as predictors of future asthma outcomes in children. Chest. 2019;155(2):331–41.PubMedCrossRef
21.
22.
23.
24.
Selroos O, Kupczyk M, Kuna P, Łacwik P, Bousquet J, Brennan D, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24(137):474–83.PubMedPubMedCentralCrossRef
25.
Li X, Song P, Zhu Y, Lei H, Chan KY, Campbell H, et al. The disease burden of childhood asthma in China: a systematic review and meta-analysis. J Glob Health. 2020;10(1):010801.PubMedPubMedCentralCrossRef
26.
27.
Lee SL, Wong W, Lau YL. Increasing prevalence of allergic rhinitis but not asthma among children in Hong Kong from 1995 to 2001 (phase 3 International Study of Asthma and allergies in Childhood). Pediatr Allergy Immunol. 2004;15(1):72–8.PubMedCrossRef
28.
Wong GW, Leung TF, Ko FW, Lee KK, Lam P, Hui DS, et al. Declining asthma prevalence in Hong Kong Chinese schoolchildren. Clin Exp Allergy. 2004;34(10):1550–5.PubMedCrossRef
29.
30.
Wang XS, Tan TN, Shek LP, Chng SY, Hia CP, Ong NB, et al. The prevalence of asthma and allergies in Singapore; data from two ISAAC surveys seven years apart. Arch Dis Child. 2004;89(5):423–6.PubMedPubMedCentralCrossRef
31.
Song WJ, Wong GWK. Changing trends and challenges in the management of asthma in Asia. J Allergy Clin Immunol. 2017;140(5):1272–4.PubMedCrossRef
32.
33.
Lawson JA, Brozek G, Shpakou A, Fedortsiv O, Vlaski E, Beridze V, et al. An international comparison of asthma, wheeze, and breathing medication use among children. Respir Med. 2017;133:22–8.PubMedCrossRef
34.
Engelkes M, Baan EJ, de Ridder MAJ, Svensson E, Prieto-Alhambra D, Lapi F, et al. Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study. Pediatr Allergy Immunol. 2020;31(5):496–505.PubMedPubMedCentralCrossRef
35.
Zhang J, Dai J, Yan L, Fu W, Yi J, Chen Y, et al. Air pollutants, Climate, and the prevalence of Pediatric Asthma in Urban areas of China. Biomed Res Int. 2016;2016:2935163.PubMedPubMedCentral
36.
Sha L, Liu C, Shao M, Chen Y. [Ten years comparison of diagnosis and treatment of asthma in urban children in China]. Zhonghua Er Ke Za Zhi. 2016;54(3):182–6.PubMed
37.
Zahran HSBC, Damon SA, Garbe PL, Breysse PN. Vital signs: Asthma in Children — United States, 2001–2016. MMWR Morb Mortal Wkly Rep. 2018;67:149–55.PubMedPubMedCentralCrossRef
38.
Zhao J, He Q, Zhang G, Chen Q, Bai J, Huang Y, et al. Status of asthma control in children and the effect of parents’ knowledge, attitude, and practice (KAP) in China: a multicenter study. Ann Allergy Asthma Immunol. 2012;109(3):190–4.PubMedCrossRef
39.
40.
Chua KL, Ma S, Prescott S, Ho MH, Ng DK, Lee BW. Trends in childhood asthma hospitalisation in three Asia Pacific countries. J Paediatr Child Health. 2011;47(10):723–7.PubMedCrossRef
41.
Fossati A, Challier C, Dalhoumi AA, Rose J, Robinson A, Perisson C et al. Telehome monitoring of symptoms and lung function in children with asthma. Healthc (Basel). 2022;10(6).
42.
Lo DK, Beardsmore CS, Roland D, Richardson M, Yang Y, Danvers L, et al. Lung function and asthma control in school-age children managed in UK primary care: a cohort study. Thorax. 2020;75(2):101–7.PubMedCrossRef
43.
Kang MG, Yoon SA, Sim JH, Woo SI. Fractional exhaled nitric oxide and forced expiratory volume in 1 second/forced vital capacity have predictive value of asthma exacerbation in Korean school children. Asia Pac Allergy. 2020;10(1):e7.PubMedPubMedCentralCrossRef
44.
45.
Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107(1):61–7.PubMedCrossRef
46.
47.
Pijnenburg MW. The role of FeNO in Predicting Asthma. Front Pead. 2019;7.
48.
Hoggins R, Velpula M, Woodward S, Tighe MP. How to use the fractional exhaled nitric oxide test. Arch Dis Child Educ Pract Ed. 2022;107(2):133–40.PubMed
49.
Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MW, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol. 2005;115(6):1130–6.PubMedCrossRef
50.
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–15.PubMedPubMedCentralCrossRef
51.
Zheng S, Hu Y, Chen Z, Wang M, Liao W. Predicting Asthma exacerbation by impulse oscillometry evaluation of small airway function and fractional exhaled nitric oxide in preschool children. Pediatr Pulmonol. 2020;55(7):1601–7.PubMedCrossRef
52.
Kim JK, Jung JY, Kim H, Eom SY, Hahn YS. Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma. Respirology. 2017;22(3):466–72.PubMedCrossRef
53.
Xepapadaki P, Korovessi P, Bachert C, Finotto S, Jartti T, Lakoumentas J et al. Evolution of Airway Inflammation in preschoolers with asthma-results of a two-year longitudinal study. J Clin Med. 2020;9(1).
54.
Ngo-Minh X, Tang-Thi-Thao T, Doan-Thi-Quynh N, Craig TJ, Duong-Quy S. Study of the role of exhaled nitric oxide (NO) in predicting controlled or uncontrolled asthma in asthmatic children. Multidiscip Respir Med. 2020;15(1):656.PubMedPubMedCentral
55.
Songnuy T, Petchuay P, Chutiyon W, Nurak A. Correlation between fractional exhaled nitric oxide level and clinical outcomes among childhood asthmatic patients: community hospital-based perspective. Heliyon. 2021;7(5):e06925.PubMedPubMedCentralCrossRef
56.
Diamant N, Amirav I, Armoni-Domany K, Sadot E, Shapira U, Cahal M, et al. High fractional exhaled nitric oxide levels in asthma patients: does size matter? Pediatr Pulmonol. 2021;56(6):1449–54.PubMedCrossRef
57.
Lin LM, Chang YJ, Yang KD, Lin CH, Chien JW, Kao JK, et al. Small Airway Dysfunction measured by Impulse Oscillometry and Fractional exhaled nitric oxide is Associated with Asthma Control in Children. Front Pediatr. 2022;10:877681.PubMedPubMedCentralCrossRef
58.
Fang C, Yang LJ, Chen XJ, Li DM, Li DX, Liang LT et al. A clinical investigation into the usefulness of fractional exhaled nitric oxide in guiding glucocorticoid therapy in children with bronchial asthma. J Physiol Pharmacol. 2022;73(4).
59.
Morphew T, Shin HW, Marchese S, Pires-Barracosa N, Galant SP. Phenotypes favoring fractional exhaled nitric oxide discordance vs guideline-based uncontrolled asthma. Ann Allergy Asthma Immunol. 2019;123(2):193–200.PubMedCrossRef
60.
Dinh-Thi-Dieu H, Vo-Thi-Kim A, Tran-Van H, Tang-Thi-Thao T, Duong-Quy S. Study of the beneficial role of exhaled nitric oxide in combination with GINA guidelines for titration of inhaled corticosteroids in children with asthma. J Breath Res. 2020;14(2):026014.PubMedCrossRef
61.
Turner S, Cotton S, Wood J, Bell V, Raja E-A, Scott NW, et al. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial. Lancet Respiratory Med. 2022;10(6):584–92.CrossRef
62.
Paracha R, Lo DKH, Montgomery U, Ryan L, Varakantam V, Gaillard EA. Asthma medication adherence and exacerbations and lung function in children managed in Leicester primary care. NPJ Prim Care Respir Med. 2023;33(1):12.PubMedPubMedCentralCrossRef
63.
64.
Levin G, Rottensctreich A, Picard E, Avital A, Springer C, Cohen S. The correlation of adenosine challenge test results with subsequent clinical course among young children with suspected asthma: a retrospective cohort study. Pediatr Pulmonol. 2019;54(7):1087–92.PubMedCrossRef
65.
Levin G, Cohen S, Springer C, Avital A, Picard E, Rottensctreich A. Factors Associated with positive Adenosine Challenge Test in Young Children with suspected asthma. Pediatr Allergy Immunol Pulmonol. 2019;32(3):103–8.PubMedPubMedCentralCrossRef
66.
Lammers N, van Hoesel MHT, Kamphuis M, Brusse-Keizer M, van der Palen J, Visser R, et al. Assessing Exercise-Induced Bronchoconstriction in Children; the need for testing. Front Pediatr. 2019;7:157.PubMedPubMedCentralCrossRef
67.
Karantaglis N, Kirvassilis F, Hatziagorou E, Gkantaras A, Kontouli K, Tsanakas J et al. Mannitol Challenge to assess therapy response in Asthmatic children: an interventional cohort study. Child (Basel). 2023;10(5).
68.
Anderson SD, Kippelen P. Assessment of EIB: what you need to know to optimize test results. Immunol Allergy Clin North Am. 2013;33(3):363–80. viii.PubMedCrossRef
69.
Sverrild A, Porsbjerg C, Backer V. The use of inhaled mannitol in the diagnosis and management of asthma. Expert Opin Pharmacother. 2012;13(1):115–23.PubMedCrossRef
70.
Afaf SA, Shannon JS, Stephen MS, Graham LH. The safety and feasibility of the inhaled mannitol challenge test in young children. Eur Respir J. 2013;42(5):1420.CrossRef
71.
Law KW, Ng KK, Yuen KN, Ho CS. Detecting asthma and bronchial hyperresponsiveness in children. Hong Kong Med J. 2000;6(1):99–104.PubMed
72.
73.
Gupta RS, Fierstein JL, Boon KL, Kanaley MK, Bozen A, Kan K, et al. Sensor-based electronic monitoring for Asthma: a Randomized Controlled Trial. Pediatrics. 2021;147(1):e20201330.PubMedCrossRef
74.
van der Kamp MR, Klaver EC, Thio BJ, Driessen JMM, de Jongh FHC, Tabak M, et al. WEARCON: wearable home monitoring in children with asthma reveals a strong association with hospital based assessment of asthma control. BMC Med Inf Decis Mak. 2020;20(1):192.CrossRef
75.
Chen J, Xu J, Zhao L, Zhang J, Yin Y, Zhang F. The effect of electronic monitoring combined with weekly feedback and reminders on adherence to inhaled corticosteroids in infants and younger children with asthma: a randomized controlled trial. Allergy Asthma Clin Immunol. 2020;16:68.PubMedPubMedCentralCrossRef
76.
Vasbinder EC, Goossens LM, Rutten-van Mölken MP, de Winter BC, van Dijk L, Vulto AG, et al. e-Monitoring of Asthma Therapy to improve compliance in children (e-MATIC): a randomised controlled trial. Eur Respir J. 2016;48(3):758–67.PubMedCrossRef
77.
Howard S, Lang A, Sharples S, Shaw D. What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective. BMJ Open Respir Res. 2016;3(1):e000159.PubMedPubMedCentralCrossRef
Metadata
Title
Objective monitoring tools for improved management of childhood asthma
Authors
Phillip L.W. Au-Doung
Jason C.H. Chan
Oliver Y.H. Kui
Marco K.Y. Ho
Yin Ting Cheung
Jenny K.W. Lam
Hak-Kim Chan
John Brannan
Kate C.C. Chan
Albert M. Li
Sharon S.Y. Leung
Publication date
03-05-2024
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2024
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-024-02817-y

Other articles of this Issue 1/2024

Respiratory Research 1/2024 Go to the issue

Review

Regulation of myofibroblast dedifferentiation in pulmonary fibrosis

Research

A novel quinoline with airway relaxant effects and anti-inflammatory properties

Research

Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study

Review

G12/13 signaling in asthma

Research

Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis

Research

Tuberculous pleural effusion-induced Arg-1+ macrophage polarization contributes to lung cancer progression via autophagy signaling

2024 ESC Congress

Noise pollution dangerous for heart health

Two studies underscore the adverse impact of noise pollution on the risk for and prognosis after myocardial infarction.

Read more

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits